503 related articles for article (PubMed ID: 23568995)
21. Amyloid peptides and proteins in review.
Harrison RS; Sharpe PC; Singh Y; Fairlie DP
Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
[TBL] [Abstract][Full Text] [Related]
22. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
23. Prion, prionoids and infectious amyloid.
Liberski PP
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S80-4. PubMed ID: 24262195
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.
Li J; Liu D; Sun L; Lu Y; Zhang Z
J Neurol Sci; 2012 Jun; 317(1-2):1-5. PubMed ID: 22410257
[TBL] [Abstract][Full Text] [Related]
25. A review on protein misfolding, aggregation and strategies to prevent related ailments.
Shamsi TN; Athar T; Parveen R; Fatima S
Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
[TBL] [Abstract][Full Text] [Related]
26. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
27. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
Melki R
J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
[TBL] [Abstract][Full Text] [Related]
28. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
Nagai Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
[TBL] [Abstract][Full Text] [Related]
29. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
30. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.
Shrivastava AN; Aperia A; Melki R; Triller A
Neuron; 2017 Jul; 95(1):33-50. PubMed ID: 28683268
[TBL] [Abstract][Full Text] [Related]
31. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
32. Critical role of transglutaminase and other stress proteins during neurodegenerative processes.
Caccamo D; Currò M; Condello S; Ferlazzo N; Ientile R
Amino Acids; 2010 Feb; 38(2):653-8. PubMed ID: 19960212
[TBL] [Abstract][Full Text] [Related]
33. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
Lee SJ; Lim HS; Masliah E; Lee HJ
Neurosci Res; 2011 Aug; 70(4):339-48. PubMed ID: 21624403
[TBL] [Abstract][Full Text] [Related]
34. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
Hachiya NS; Kozuka Y; Kaneko K
Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
[TBL] [Abstract][Full Text] [Related]
35. TDP-43 Prions.
Nonaka T; Hasegawa M
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108532
[TBL] [Abstract][Full Text] [Related]
36. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
37. Role of molecular chaperones in neurodegenerative disorders.
Meriin AB; Sherman MY
Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapeutic Approaches for the Treatment of Neurodegenerative Diseases: Challenges and Outcomes.
Sushma ; Mondal AC
CNS Neurol Disord Drug Targets; 2023; 22(3):404-416. PubMed ID: 34963438
[TBL] [Abstract][Full Text] [Related]
39. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
[TBL] [Abstract][Full Text] [Related]
40. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
Rockenstein E; Crews L; Masliah E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
